Search
 
NEWS
 

Gene-editing Therapy EDIT-301 Promising in 1st RUBY Patients |... - Sickle Cell Anemia News

 
 
The first two patients treated with the gene editing therapy EDIT-301 showed engraftment in the RUBY clinical trial, Editas Medicine said. - READ MORE
By Sickle Cell Anemia News
Thu, 08 Dec 2022 16:06:46 GMT
 
PREVIOUS NEXT
Tagged: #Therapy #Promising #RUBY #Patients #Sickle #Cell #Anemia #News
ADD COMMENT
Topic
Name
1+1 =